Jamie Stockton
Stock Analyst at Wells Fargo
(2.38)
# 2,290
Out of 4,814 analysts
22
Total ratings
46.67%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Jamie Stockton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $175 → $200 | $6.83 | +2,828.26% | 5 | Oct 29, 2020 | |
| OMCL Omnicell | Maintains: Equal-Weight | $74 → $84 | $30.27 | +177.50% | 2 | Oct 28, 2020 | |
| HQY HealthEquity | Maintains: Overweight | $63 → $70 | $84.52 | -17.18% | 6 | Sep 9, 2020 | |
| EVH Evolent Health | Maintains: Overweight | $19 → $17 | $8.97 | +89.52% | 2 | Jan 8, 2020 | |
| MMS Maximus | Maintains: Equal-Weight | $83 → $81 | $67.23 | +20.48% | 3 | Jan 8, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | $140 → $160 | $143.91 | +11.18% | 2 | Feb 19, 2019 | |
| EHTH eHealth | Maintains: Market Perform | $18 → $24 | $5.91 | +306.44% | 2 | Oct 19, 2017 |
Teladoc Health
Oct 29, 2020
Maintains: Equal-Weight
Price Target: $175 → $200
Current: $6.83
Upside: +2,828.26%
Omnicell
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $74 → $84
Current: $30.27
Upside: +177.50%
HealthEquity
Sep 9, 2020
Maintains: Overweight
Price Target: $63 → $70
Current: $84.52
Upside: -17.18%
Evolent Health
Jan 8, 2020
Maintains: Overweight
Price Target: $19 → $17
Current: $8.97
Upside: +89.52%
Maximus
Jan 8, 2020
Maintains: Equal-Weight
Price Target: $83 → $81
Current: $67.23
Upside: +20.48%
IQVIA Holdings
Feb 19, 2019
Maintains: Outperform
Price Target: $140 → $160
Current: $143.91
Upside: +11.18%
eHealth
Oct 19, 2017
Maintains: Market Perform
Price Target: $18 → $24
Current: $5.91
Upside: +306.44%